Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis
Introduction: <i>Pseudomonas aeruginosa</i> (PA) is a leading cause of healthcare-associated infections. A variety of antibiotic classes are used in the treatment of PA infections, including beta-lactams (BLs) and fluoroquinolones (FQs), given either together in combination therapy or al...
Saved in:
Main Authors: | Eric Reid (Author), Ryan W. Walters (Author), Christopher J. Destache (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
by: Sitong Liu, et al.
Published: (2019) -
Potential Synergistic Antibiotic Combinations against Fluoroquinolone-Resistant <i>Pseudomonas aeruginosa</i>
by: Ashish Kothari, et al.
Published: (2022) -
Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Worapong Nasomsong, et al.
Published: (2022) -
Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023) -
Penetration through Outer Membrane and Efflux Potential in <i>Pseudomonas aeruginosa</i> of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
by: Choon Kim, et al.
Published: (2023)